Literature DB >> 19941094

Role of cardiac imaging evaluation of patients with documented or suspected ventricular arrhythmias.

Naveen Jonnalagadda1, Aditya Jain, Hugh Calkins, Harikrishna Tandri.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 19941094     DOI： 10.1007/s12350-009-9168-8

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  37 in total

1.  Sudden cardiac death in the young.

Authors:  Christopher Semsarian; Barry J Maron
Journal:  Med J Aust       Date:  2002-02-18       Impact factor: 7.738

2.  Heart failure in arrhythmogenic right ventricular dysplasia-cardiomyopathy.

Authors:  S Peters; H Peters; L Thierfelder
Journal:  Int J Cardiol       Date:  1999-12-01       Impact factor: 4.164

3.  Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.

Authors:  Stijntje D Roes; C Jan Willem Borleffs; Rob J van der Geest; Jos J M Westenberg; Nina Ajmone Marsan; Theodorus A M Kaandorp; Johan H C Reiber; Katja Zeppenfeld; Hildo J Lamb; Albert de Roos; Martin J Schalij; Jeroen J Bax
Journal:  Circ Cardiovasc Imaging       Date:  2009-03-23       Impact factor: 7.792

4.  Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives.

Authors:  Hanno L Tan; Nynke Hofman; Irene M van Langen; Allard C van der Wal; Arthur A M Wilde
Journal:  Circulation       Date:  2005-07-05       Impact factor: 29.690

5.  Ventricular fibrillation without apparent heart disease: description of six cases.

Authors:  B Martini; A Nava; G Thiene; G F Buja; B Canciani; R Scognamiglio; L Daliento; S Dalla Volta
Journal:  Am Heart J       Date:  1989-12       Impact factor: 4.749

6.  Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging.

Authors:  T Shimada; K Shimada; T Sakane; K Ochiai; H Tsukihashi; M Fukui; S Inoue; H Katoh; Y Murakami; Y Ishibashi; R Maruyama
Journal:  Am J Med       Date:  2001-05       Impact factor: 4.965

7.  Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging.

Authors:  Harikrishna Tandri; Manoj Saranathan; E Rene Rodriguez; Claudia Martinez; Chandra Bomma; Khurram Nasir; Boas Rosen; João A C Lima; Hugh Calkins; David A Bluemke
Journal:  J Am Coll Cardiol       Date:  2005-01-04       Impact factor: 24.094

8.  Postpartum complete atrioventricular block due to cardiac sarcoidosis: steroid therapy without permanent pacemaker.

Authors:  Kazuro Sugishita; Yuki Togashi; Akira Aizawa; Masako Asakawa; Shin-ichi Usui; Nobuhiko Ito; Tetsuo Yamaguchi; Yoshiyuki Hada; Toshiyuki Takahashi
Journal:  Int Heart J       Date:  2008-05       Impact factor: 1.862

9.  Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate.

Authors:  Frank M Bogun; Benoit Desjardins; Eric Good; Sanjaya Gupta; Thomas Crawford; Hakan Oral; Matthew Ebinger; Frank Pelosi; Aman Chugh; Krit Jongnarangsin; Fred Morady
Journal:  J Am Coll Cardiol       Date:  2009-03-31       Impact factor: 24.094

10.  Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction.

Authors:  Heikki V Huikuri; M J Pekka Raatikainen; Rikke Moerch-Joergensen; Juha Hartikainen; Vesa Virtanen; Jean Boland; Olli Anttonen; Nis Hoest; Lucas V A Boersma; Eivind S Platou; Marc D Messier; Poul-Erik Bloch-Thomsen
Journal:  Eur Heart J       Date:  2009-01-20       Impact factor: 29.983
View more
  1 in total

Review 1.  Korean guidelines for the appropriate use of cardiac CT.

Authors:  Young Jin Kim; Hwan Seok Yong; Sung Mok Kim; Jeong A Kim; Dong Hyun Yang; Yoo Jin Hong
Journal:  Korean J Radiol       Date:  2015-02-27       Impact factor: 3.500
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.